nodes	percent_of_prediction	percent_of_DWPC	metapath
Vancomycin—Urinary tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00652	0.00652	CcSEcCtD
Vancomycin—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.0064	0.0064	CcSEcCtD
Vancomycin—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.0064	0.0064	CcSEcCtD
Vancomycin—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.0062	0.0062	CcSEcCtD
Vancomycin—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00616	0.00616	CcSEcCtD
Vancomycin—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00604	0.00604	CcSEcCtD
Vancomycin—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00594	0.00594	CcSEcCtD
Vancomycin—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00593	0.00593	CcSEcCtD
Vancomycin—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00592	0.00592	CcSEcCtD
Vancomycin—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00589	0.00589	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00588	0.00588	CcSEcCtD
Vancomycin—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00587	0.00587	CcSEcCtD
Vancomycin—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00582	0.00582	CcSEcCtD
Vancomycin—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00557	0.00557	CcSEcCtD
Vancomycin—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00541	0.00541	CcSEcCtD
Vancomycin—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00538	0.00538	CcSEcCtD
Vancomycin—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00537	0.00537	CcSEcCtD
Vancomycin—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00531	0.00531	CcSEcCtD
Vancomycin—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00531	0.00531	CcSEcCtD
Vancomycin—Urinary tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00527	0.00527	CcSEcCtD
Vancomycin—Urinary tract infection—Formoterol—chronic obstructive pulmonary disease	0.00527	0.00527	CcSEcCtD
Vancomycin—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00526	0.00526	CcSEcCtD
Vancomycin—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00525	0.00525	CcSEcCtD
Vancomycin—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00507	0.00507	CcSEcCtD
Vancomycin—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00502	0.00502	CcSEcCtD
Vancomycin—Urinary tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00497	0.00497	CcSEcCtD
Vancomycin—Fungal infection—Prednisone—chronic obstructive pulmonary disease	0.00494	0.00494	CcSEcCtD
Vancomycin—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00492	0.00492	CcSEcCtD
Vancomycin—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00488	0.00488	CcSEcCtD
Vancomycin—Necrosis—Prednisone—chronic obstructive pulmonary disease	0.00486	0.00486	CcSEcCtD
Vancomycin—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00479	0.00479	CcSEcCtD
Vancomycin—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00479	0.00479	CcSEcCtD
Vancomycin—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00478	0.00478	CcSEcCtD
Vancomycin—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00478	0.00478	CcSEcCtD
Vancomycin—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00468	0.00468	CcSEcCtD
Vancomycin—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00464	0.00464	CcSEcCtD
Vancomycin—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00454	0.00454	CcSEcCtD
Vancomycin—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00451	0.00451	CcSEcCtD
Vancomycin—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00451	0.00451	CcSEcCtD
Vancomycin—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.0045	0.0045	CcSEcCtD
Vancomycin—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.0045	0.0045	CcSEcCtD
Vancomycin—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00445	0.00445	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00444	0.00444	CcSEcCtD
Vancomycin—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00443	0.00443	CcSEcCtD
Vancomycin—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.0044	0.0044	CcSEcCtD
Vancomycin—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00433	0.00433	CcSEcCtD
Vancomycin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00429	0.00429	CcSEcCtD
Vancomycin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00429	0.00429	CcSEcCtD
Vancomycin—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00428	0.00428	CcSEcCtD
Vancomycin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00426	0.00426	CcSEcCtD
Vancomycin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00426	0.00426	CcSEcCtD
Vancomycin—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00425	0.00425	CcSEcCtD
Vancomycin—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00424	0.00424	CcSEcCtD
Vancomycin—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00423	0.00423	CcSEcCtD
Vancomycin—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00423	0.00423	CcSEcCtD
Vancomycin—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.0042	0.0042	CcSEcCtD
Vancomycin—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00418	0.00418	CcSEcCtD
Vancomycin—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00416	0.00416	CcSEcCtD
Vancomycin—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00412	0.00412	CcSEcCtD
Vancomycin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00411	0.00411	CcSEcCtD
Vancomycin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.0041	0.0041	CcSEcCtD
Vancomycin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.0041	0.0041	CcSEcCtD
Vancomycin—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Vancomycin—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00407	0.00407	CcSEcCtD
Vancomycin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00404	0.00404	CcSEcCtD
Vancomycin—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.004	0.004	CcSEcCtD
Vancomycin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00399	0.00399	CcSEcCtD
Vancomycin—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.00398	0.00398	CcSEcCtD
Vancomycin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00394	0.00394	CcSEcCtD
Vancomycin—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00393	0.00393	CcSEcCtD
Vancomycin—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.0039	0.0039	CcSEcCtD
Vancomycin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Vancomycin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00387	0.00387	CcSEcCtD
Vancomycin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00384	0.00384	CcSEcCtD
Vancomycin—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Vancomycin—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.00374	0.00374	CcSEcCtD
Vancomycin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00371	0.00371	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.0037	0.0037	CcSEcCtD
Vancomycin—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Vancomycin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00366	0.00366	CcSEcCtD
Vancomycin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00361	0.00361	CcSEcCtD
Vancomycin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Vancomycin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Vancomycin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00359	0.00359	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00358	0.00358	CcSEcCtD
Vancomycin—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00353	0.00353	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00351	0.00351	CcSEcCtD
Vancomycin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.0035	0.0035	CcSEcCtD
Vancomycin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Vancomycin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00346	0.00346	CcSEcCtD
Vancomycin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Vancomycin—Infection—Formoterol—chronic obstructive pulmonary disease	0.00343	0.00343	CcSEcCtD
Vancomycin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.0034	0.0034	CcSEcCtD
Vancomycin—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Vancomycin—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00339	0.00339	CcSEcCtD
Vancomycin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Vancomycin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00338	0.00338	CcSEcCtD
Vancomycin—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Vancomycin—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00337	0.00337	CcSEcCtD
Vancomycin—Infection—Montelukast—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Vancomycin—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Vancomycin—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00336	0.00336	CcSEcCtD
Vancomycin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00334	0.00334	CcSEcCtD
Vancomycin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00332	0.00332	CcSEcCtD
Vancomycin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00331	0.00331	CcSEcCtD
Vancomycin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00329	0.00329	CcSEcCtD
Vancomycin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00326	0.00326	CcSEcCtD
Vancomycin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00324	0.00324	CcSEcCtD
Vancomycin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Vancomycin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00323	0.00323	CcSEcCtD
Vancomycin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00321	0.00321	CcSEcCtD
Vancomycin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Vancomycin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.0032	0.0032	CcSEcCtD
Vancomycin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00318	0.00318	CcSEcCtD
Vancomycin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00317	0.00317	CcSEcCtD
Vancomycin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00315	0.00315	CcSEcCtD
Vancomycin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Vancomycin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00312	0.00312	CcSEcCtD
Vancomycin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00308	0.00308	CcSEcCtD
Vancomycin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00308	0.00308	CcSEcCtD
Vancomycin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00306	0.00306	CcSEcCtD
Vancomycin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00305	0.00305	CcSEcCtD
Vancomycin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00303	0.00303	CcSEcCtD
Vancomycin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.003	0.003	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Vancomycin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Vancomycin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00298	0.00298	CcSEcCtD
Vancomycin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Vancomycin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Vancomycin—Pain—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Vancomycin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Vancomycin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00295	0.00295	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Vancomycin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00292	0.00292	CcSEcCtD
Vancomycin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.00291	CcSEcCtD
Vancomycin—Pain—Montelukast—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Vancomycin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00289	0.00289	CcSEcCtD
Vancomycin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Vancomycin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00286	0.00286	CcSEcCtD
Vancomycin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00284	0.00284	CcSEcCtD
Vancomycin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Vancomycin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Vancomycin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00283	0.00283	CcSEcCtD
Vancomycin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00282	0.00282	CcSEcCtD
Vancomycin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00281	0.00281	CcSEcCtD
Vancomycin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00279	CcSEcCtD
Vancomycin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00279	CcSEcCtD
Vancomycin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00277	0.00277	CcSEcCtD
Vancomycin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00274	0.00274	CcSEcCtD
Vancomycin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00274	0.00274	CcSEcCtD
Vancomycin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Vancomycin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Vancomycin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Vancomycin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00273	0.00273	CcSEcCtD
Vancomycin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00272	0.00272	CcSEcCtD
Vancomycin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Vancomycin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Vancomycin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.0027	CcSEcCtD
Vancomycin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00269	0.00269	CcSEcCtD
Vancomycin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00268	0.00268	CcSEcCtD
Vancomycin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00268	0.00268	CcSEcCtD
Vancomycin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00268	0.00268	CcSEcCtD
Vancomycin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00268	0.00268	CcSEcCtD
Vancomycin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00267	0.00267	CcSEcCtD
Vancomycin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00259	0.00259	CcSEcCtD
Vancomycin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Vancomycin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00258	0.00258	CcSEcCtD
Vancomycin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Vancomycin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00255	0.00255	CcSEcCtD
Vancomycin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00254	CcSEcCtD
Vancomycin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.00252	0.00252	CcSEcCtD
Vancomycin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00249	0.00249	CcSEcCtD
Vancomycin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00248	CcSEcCtD
Vancomycin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00248	CcSEcCtD
Vancomycin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Vancomycin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00244	CcSEcCtD
Vancomycin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00243	0.00243	CcSEcCtD
Vancomycin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.0024	CcSEcCtD
Vancomycin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00239	0.00239	CcSEcCtD
Vancomycin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00234	0.00234	CcSEcCtD
Vancomycin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00231	CcSEcCtD
Vancomycin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00229	0.00229	CcSEcCtD
Vancomycin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Vancomycin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00228	CcSEcCtD
Vancomycin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Vancomycin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00224	0.00224	CcSEcCtD
Vancomycin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Vancomycin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0022	0.0022	CcSEcCtD
Vancomycin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Vancomycin—Rash—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Vancomycin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Vancomycin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00218	CcSEcCtD
Vancomycin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Vancomycin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Vancomycin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00216	CcSEcCtD
Vancomycin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00215	0.00215	CcSEcCtD
Vancomycin—Rash—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00213	CcSEcCtD
Vancomycin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00213	0.00213	CcSEcCtD
Vancomycin—Headache—Montelukast—chronic obstructive pulmonary disease	0.00212	0.00212	CcSEcCtD
Vancomycin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00207	0.00207	CcSEcCtD
Vancomycin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Vancomycin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Vancomycin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00206	CcSEcCtD
Vancomycin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Vancomycin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00205	CcSEcCtD
Vancomycin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00204	CcSEcCtD
Vancomycin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00201	CcSEcCtD
Vancomycin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00195	0.00195	CcSEcCtD
Vancomycin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00194	CcSEcCtD
Vancomycin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00188	0.00188	CcSEcCtD
Vancomycin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00187	0.00187	CcSEcCtD
Vancomycin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00183	0.00183	CcSEcCtD
Vancomycin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00178	0.00178	CcSEcCtD
Vancomycin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00169	0.00169	CcSEcCtD
Vancomycin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Vancomycin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00167	0.00167	CcSEcCtD
Vancomycin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.0016	CcSEcCtD
Vancomycin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00154	CcSEcCtD
Vancomycin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.0015	0.0015	CcSEcCtD
Vancomycin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00149	0.00149	CcSEcCtD
Vancomycin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.00141	0.00141	CcSEcCtD
Vancomycin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00138	0.00138	CcSEcCtD
Vancomycin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00136	CcSEcCtD
Vancomycin—Infection—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00135	CcSEcCtD
Vancomycin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Vancomycin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.00133	0.00133	CcSEcCtD
Vancomycin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00132	0.00132	CcSEcCtD
Vancomycin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00124	CcSEcCtD
Vancomycin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00123	0.00123	CcSEcCtD
Vancomycin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Vancomycin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00118	CcSEcCtD
Vancomycin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Vancomycin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00117	CcSEcCtD
Vancomycin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00116	CcSEcCtD
Vancomycin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vancomycin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00111	CcSEcCtD
Vancomycin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00108	CcSEcCtD
Vancomycin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Vancomycin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00107	CcSEcCtD
Vancomycin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.001	0.001	CcSEcCtD
Vancomycin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000976	0.000976	CcSEcCtD
Vancomycin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000962	0.000962	CcSEcCtD
Vancomycin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000899	0.000899	CcSEcCtD
Vancomycin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000865	0.000865	CcSEcCtD
Vancomycin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000857	0.000857	CcSEcCtD
Vancomycin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000857	0.000857	CcSEcCtD
Vancomycin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000852	0.000852	CcSEcCtD
Vancomycin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000808	0.000808	CcSEcCtD
